<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMortality_study</id>
	<title>Definition:Mortality study - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AMortality_study"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Mortality_study&amp;action=history"/>
	<updated>2026-06-14T01:59:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Mortality_study&amp;diff=13458&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Mortality_study&amp;diff=13458&amp;oldid=prev"/>
		<updated>2026-03-13T12:57:26Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📈 &amp;#039;&amp;#039;&amp;#039;Mortality study&amp;#039;&amp;#039;&amp;#039; is a systematic [[Definition:Actuarial science | actuarial]] investigation that analyzes death rates within a defined population to develop, validate, or update the [[Definition:Mortality table | mortality assumptions]] used in pricing, reserving, and managing [[Definition:Life insurance | life insurance]], [[Definition:Annuity | annuity]], and [[Definition:Pension | pension]] products. These studies form the empirical backbone of the life insurance industry, translating raw experience data into the statistical models that determine how much [[Definition:Premium | premium]] to charge, how large [[Definition:Policy reserve | reserves]] must be, and how long [[Definition:Policyholder | policyholders]] or annuitants are expected to live. Whether conducted by individual carriers, [[Definition:Reinsurer | reinsurers]], industry bodies, or regulatory organizations, mortality studies are among the most consequential analytical exercises in the insurance sector.&lt;br /&gt;
&lt;br /&gt;
⚙️ Conducting a mortality study involves collecting exposure and claims data over a defined observation period, typically spanning multiple years, and analyzing actual deaths relative to expected deaths under a reference [[Definition:Mortality table | mortality table]]. The study measures actual-to-expected (A/E) ratios across various dimensions — age, gender, [[Definition:Underwriting class | underwriting class]], product type, policy duration, smoking status, and other risk factors — to identify where experience deviates from assumptions. Large insurers and reinsurers conduct proprietary studies using their own book data, while organizations such as the [[Definition:Society of Actuaries (SOA) | Society of Actuaries]] in the United States, the [[Definition:Continuous Mortality Investigation (CMI) | Continuous Mortality Investigation]] in the United Kingdom, and analogous bodies in Japan, Germany, and other markets publish industry-wide tables derived from pooled data. These published tables — such as the SOA&amp;#039;s Valuation Basic Tables or the CMI&amp;#039;s mortality projections — serve as benchmarks that regulators often mandate or reference for [[Definition:Statutory reserve | statutory reserving]] and [[Definition:Solvency | solvency]] calculations.&lt;br /&gt;
&lt;br /&gt;
💡 The insights generated by mortality studies ripple through virtually every aspect of life insurance operations. When a study reveals that mortality is improving faster than anticipated — a trend known as [[Definition:Longevity risk | longevity improvement]] — annuity writers face increased liabilities, while life insurers may benefit from lower-than-expected claims. Conversely, events like the COVID-19 pandemic triggered ad hoc mortality studies across global markets to quantify excess deaths and recalibrate near-term assumptions. Regulatory frameworks reflect the centrality of these studies: under [[Definition:IFRS 17 | IFRS 17]], insurers must use current best-estimate mortality assumptions that are regularly updated based on experience analysis, while [[Definition:Solvency II | Solvency II]] requires explicit stress testing of mortality and longevity assumptions in the [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]] calculation. As data availability expands — through [[Definition:Electronic health record | electronic health records]], wearable devices, and enhanced [[Definition:Predictive analytics | predictive analytics]] — the granularity and frequency of mortality studies continue to increase, enabling more accurate and responsive pricing across the life insurance industry.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Mortality table]]&lt;br /&gt;
* [[Definition:Actuarial science]]&lt;br /&gt;
* [[Definition:Longevity risk]]&lt;br /&gt;
* [[Definition:Life insurance]]&lt;br /&gt;
* [[Definition:Policy reserve]]&lt;br /&gt;
* [[Definition:Underwriting class]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>